Shareholder announcement
February 06, 2009 03:18 ET
|
ALK Abello
Pursuant to section 28(a) of the Danish Public Companies Act and section 29 of
the Danish Securities Trading Act, ALK has received notification from ATP (the
Danish Labour Market Supplementary...
Ejermeddelelse
February 06, 2009 03:18 ET
|
ALK Abello
I henhold til Aktieselskabslovens § 28a og Værdipapirhandelslovens § 29 har ALK
modtaget meddelelse fra ATP om, at ATP og ATP Invest, Hillerød, efter salg har
nedbragt deres ejerandele i ALK-Abelló...
Release date of annual report 2008 for ALK and analyst meeting
February 05, 2009 09:15 ET
|
ALK Abello
ALK releases its annual report 2008 on Thursday, February 19, 2009.
The company therefore invites analysts and investors to a meeting with
Management on Friday, February 20, at 09.00 a.m. at the...
Dato for offentliggørelse af årsrapport 2008 for ALK og analytikermøde
February 05, 2009 09:15 ET
|
ALK Abello
ALK offentliggør årsrapport for 2008 torsdag den 19. februar 2009.
I den forbindelse inviteres analytikere og investorer til møde fredag den 20.
februar kl.09.00 på selskabets adresse, Bøge Allé...
ALK køber aktier i den franske virksomhed DBV Technologies
January 22, 2009 02:01 ET
|
ALK Abello
Resume: ALK investerer i udvikling af vaccine mod peanutallergi
ALK har indgået aftale om at investere 2 mio. EUR i den franske
biotekvirksomhed DBV Technologies som en del af en opfølgende...
ALK acquires shares in DBV Technologies, France
January 22, 2009 02:01 ET
|
ALK Abello
Summary: ALK invests in development of a peanut allergy vaccine
ALK has signed an agreement to invest EUR 2 million in the French biotech
company DBV Technologies as part of a follow-up equity...
for regnskabsåret 2009
December 15, 2008 07:35 ET
|
ALK Abello
- Årsrapport 2008 19. februar 2009
- Ordinær generalforsamling 27. marts 2009
Den Sorte Diamant kl. 16.00
Søren Kierkegaards Plads
1221 ...
for the 2009 financial year
December 15, 2008 07:35 ET
|
ALK Abello
- Annual report 2008 February 19, 2009
- Annual General Meeting March 27, 2009
Den Sorte Diamant 4.00 p.m.
Søren Kierkegaards Plads
1221...
ALK achieves general reimbursement for GRAZAX® in Spain
November 21, 2008 07:52 ET
|
ALK Abello
The Spanish authorities today announced that they have finalized the evaluation
of ALK's application for price and reimbursement of the company's tablet based
vaccine against grass pollen allergy...
ALK opnår generelt tilskud til GRAZAX® i Spanien
November 21, 2008 07:52 ET
|
ALK Abello
De spanske myndigheder har i dag meddelt, at behandlingen af ALKs ansøgning om
pris og tilskud til selskabets tabletbaserede vaccine mod græspollenallergi er
afsluttet med positivt udfald. GRAZAX®...